Hereditary Sideroblastic Anemia and Glucose-6-Phosphate Dehydrogenase Deficiency in a Negro Family

Total Page:16

File Type:pdf, Size:1020Kb

Hereditary Sideroblastic Anemia and Glucose-6-Phosphate Dehydrogenase Deficiency in a Negro Family Hereditary sideroblastic anemia and glucose-6-phosphate dehydrogenase deficiency in a negro family Ananda S. Prasad, … , Charles F. Sing, George J. Brewer J Clin Invest. 1968;47(6):1415-1424. https://doi.org/10.1172/JCI105833. Research Article Detailed clinical and genetic studies have been performed in a Negro family, which segregated for sex-linked sideroblastic anemia and glucose-6-phosphate dehydrogenase (G-6-DP) deficiency. This is the first such pedigree reported. Males affected with sideroblastic anemia had growth retardation, hypochromic microcytic anemia, elevated serum iron, decreased unsaturated iron-binding capacity, increased 59Fe clearance, low 59Fe incorporation into erythrocytes, normal erythrocyte survival (51Cr), normal hemoglobin electrophoretic pattern, erythroblastic hyperplasia of marrow with increased iron, and marked increase in marrow sideroblasts, particularly ringed sideroblasts. Perinuclear deposition of ferric aggregates was demonstrated to be intramitochondrial by electron microscopy. Female carriers of the sideroblastic gene were normal but exhibited a dimorphic population of erythrocytes including normocytic and microcytic cells. The bone marrow studies in the female (mother) showed ringed marrow sideroblasts. Studies of G-6-PD involved the methemoglobin elution test for G-6-PD activity of individual erythrocytes, quantitative G-6- PD assay, and electrophoresis. In the pedigree, linkage information was obtained from a doubly heterozygous woman, four of her sons, and five of her daughters. Three sons were doubly affected, and one was normal. One daughter appeared to be a recombinant. The genes appeared to be linked in the coupling phase in the mother. The maximum likelihood estimate of the recombination value was 0.14. By means of Price-Jones curves, the microcytic red cells in peripheral blood were quantitated in female […] Find the latest version: https://jci.me/105833/pdf Hereditary Sideroblastic Anemia and Glucose- 6-Phosphate Dehydrogenase Deficiency in a Negro Family ANANDA S. PRAsAD, LIBomo TRANCHIDA, EDWARD T. KONNO, LAWRENCE BERMAN, SAMuEL ALBERT, CHARLES F. SING, and GEORGE J. BREwER From the Departments of Medicine and Pathology, Wayne State University, School of Medicine, Detroit, Michigan, Veterans Administration Hospital, Allen Park, Michigan, the Detroit Institute for Cancer Research, and the Depart- ments of Human Genetics and Medicine (Simpson Memorial Institute), University of Michigan Medical School, Ann Arbor, Michigan 48207 A BSTRACT Detailed clinical and genetic stud- Studies of G-6-PD involved the methemoglobin ies have been performed in a Negro family, which elution test for G-6-PD activity of individual segregated for sex-linked sideroblastic anemia and erythrocytes, quantitative G-6-PD assay, and elec- glucose-6-phosphate dehydrogenase (G-6-DP) de- trophoresis. In the pedigree, linkage information ficiency. This is the first such pedigree reported. was obtained from a doubly heterozygous woman, Males affected with sideroblastic anemia had four of her sons, and five of her daughters. Three growth retardation, hypochromic microcytic ane- sons were doubly affected, and one was normal. mia, elevated serum iron, decreased unsaturated One daughter appeared to be a recombinant. The iron-binding capacity, increased 59Fe clearance, genes appeared to be linked in the coupling phase low 59Fe incorporation into erythrocytes, normal in the mother. The maximum likelihood estimate erythrocyte survival (51Cr), normal hemoglobin of the recombination value was 0.14. electrophoretic pattern, erythroblastic hyperplasia By means of Price-Jones curves, the microcytic of marrow with increased iron, and marked in- red cells in peripheral blood were quantitated in crease in marrow sideroblasts, particularly ringed female carriers. The sideroblast count in the bone sideroblasts. Perinuclear deposition of ferric ag- marrow in the mother corresponded closely to the gregates was demonstrated to be intramitochon- percentage of microcytic cells in peripheral blood. drial by electron microscopy. Female carriers of This is the second example in which the cellular the sideroblastic gene were normal but exhibited expression of a sex-linked trait has been docu- a dimorphic population of erythrocytes including mented in the human red cells, the first one being normocytic and microcytic cells. The bone marrow G-6-PD deficiency. The coexistence of the two studies in the female (mother) showed ringed genes in doubly heterozygous females has made it marrow sideroblasts. possible to study correlations in cell counts; our studies showed a strong positive correlation except This paper was presented at the 10th Annual Meeting of the American Society of Hematology, Toronto, Canada, in the probable recombinant in which a reciprocal 3 December 1967. relation held which indicated that X-inactivation Address requests for reprints to Dr. Ananda S. Prasad, was at least regional, rather than locus by locus. Department of Medicine, Wayne State University, School of Medicine, 1400 Chrysler Freeway, Detroit, Mich. INTRODUCTION 48207. Received for publication 27 December 1967 and in re- Several investigators (1-21) have described the vised form 19 February 1968. occurrence of a hypochromic microcytic anemia, The Journal of Clinical Investigation Volume 47 1968 1415 not due to iron deficiency or thalassemia, which plastin time, one stage prothrombin time, accelerator- seemed to be familial. The mode of inheritance globulin, antihemophilic globulin, antithrombin, thrombin appeared to be sex-linked, but sufficient data to time, and euglobulin lysis time (33).1 Studies of G-6-PD involved the methemoglobin elu- determine this with some certainty have been pre- tion test (MET) for G-6-PD activity of individual sented in only a few instances (1-5). In those erythrocytes (34), quantitative G-6-PD assay (35), and cases in which bone marrow studies were per- starch-gel electrophoresis (36). The activities of aldolase, formed, an excessive number of sideroblasts was lactic, and malic dehydrogenases in the red blood cells were determined in several subjects with kits made avail- seen and the entity has been called hereditary sex- able by Calbiochem, Los Angeles, Calif. Pyruvic kinase linked sideroblastic anemia. activity in the red cells was measured according to the This paper presents studies of the first Negro method of Tanaka, Valentine, and Miwa (37). Glycer- family with sex-linked sideroblastic anemia. This aldehyde-3-phosphate dehydrogenase activity of red cells family is also the first to be studied in which glu- was assayed by the method of Bergmeyer (38). cose-6-phosphate dehydrogenase (G-6-PD) de- RESULTS coexists ficiency with sideroblastic anemia. This Pedigree and clinical has provided us with a unique observations in affected opportunity to males study the linkage of the two genes and to study the relationships of the cellular expressions of The pedigree is shown in Fig. 1. The affected 2 the two genes in various genotypes, particularly males (II-2, II-3, and II-16) were 12, 11, and 15 double heterozygotes. yr old, respectively. All three were essentially asymptomatic except for dyspnea on exertion. 5 METHODS yr before this study they were diagnosed elsewhere Three doubly affected boys, seven heterozygous carriers as having anemia of unknown eitology. One male of one or the other gene, three presumed normal, and sibling, II-14, died in 1961, also with a diagnosis three G-6-PD-deficient members of this family were studied in detail. Besides history, physical examination, of anemia of undetermined etiology. This patient, and routine blood tests (fasting blood sugar, blood urea II-14, was said to have a bleeding diathesis. In nitrogen, serum bilirubin, alkaline phosphatase, calcium this connection, it is of interest that one of the phosphorus, and total lipids) complete hematological affected males, II-16, under investigation was ad- studies including bone marrow examination were carried mitted to the hospital during this study because out. The bone marrow smears were stained for iron (22) and the number of abnormal sideroblasts were counted of epistaxis. (23). Normoblasts containing more than five coarse fer- All three boys were anemic and physically ric aggregates or those containing aggregates arranged underdeveloped for their ages (below three per- around the nucleus (ringed type) were considered abnor- centiles of normal curves for height and weight). mal (23). In addition, the bone marrow was fixed in buf- fered glutaraldehyde (24) and postfixed in 1% osmium The spleen was barely palpable in two of the three tetroxide (25) for electron microscopic examination. cases and was not felt in the third. No evidence Fetal hemoglobin and electrophoretic patterns were per- of color blindness was obtained in any of the formed by standard methods (26). Serum iron and un- family members. saturated iron-binding capacity were determined by the Anemia was moderately severe in the affected methods as outlined by Meites and Faulkner (27). The plasma disappearance rate of '9Fe and its incorporation boys (Table I, II-2, II-3, and II-16). Blood films into red cells was also measured (28). Erythrocyte sur- of the peripheral blood stained with Wright's vival was measured by the use of "Cr-labeled red blood stain revealed the presence of markedly hypo- cells (29). Price-Jones curves were obtained by measur- chromic microcytic cells, with extreme poikilo- ing two diameters and taking the average for each red cytosis- Hemoglobin was of the
Recommended publications
  • Kawasaki Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Case Report
    Saudi Pharmaceutical Journal (2014) xxx, xxx–xxx King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com CASE REPORT Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report Hesham Radi Obeidat a,*, Sahar Al-Dossary b, Abdulsalam Asseri a a Pharmacy Department, Saad Specialist Hospital, Alkhobar 31952, Saudi Arabia b Pediatric and Neonatology Department, Saad Specialist Hospital, Alkhobar 31952, Saudi Arabia Received 28 August 2014; accepted 11 November 2014 KEYWORDS Abstract Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that Kawasaki disease; occurs predominantly in infants and children younger than 5 years of age. Coronary artery abnor- G6PD; malities are the most serious complication. Aspirin Based on the literatures infusion of Intravenous Immunoglobulin of 2 g/kg and a high dose of oral aspirin up to 100 mg/kg/day are the standard treatment for Kawasaki disease in the acute stage, and should be followed by antiplatelet dose of aspirin for thrombocytosis. Glucose-6-Phos- phate Dehydrogenase (G6PD) deficiency is an inherited X-linked hereditary disorder, and aspirin can induce hemolysis in patients with G6PD deficiency. We report a case of a 5 year and 8 month old male with KD and G6PD deficiency. ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). 1. Introduction genetic predisposition or infectious agents are likely to be the cause. Kawasaki disease was first described in 1967 by Tomisaku Recently, guidelines were published by the American Heart Kawasaki and has replaced acute rheumatic fever as the lead- Association (AHA) to aid in the diagnosis and management of ing cause of acquired heart disease among children in devel- Kawasaki disease.
    [Show full text]
  • Hemolytic Anemia Caused by Hereditary Pyruvate Kinase Deficiency in a West Highland White Terrier Dog
    Arch Med Vet 44, 195-200 (2012) COMMUNICATION Hemolytic anemia caused by hereditary pyruvate kinase deficiency in a West Highland White Terrier dog Anemia hemolítica causada por la deficiencia de piruvato quinasa hereditaria en un perro West Highland White Terrier NRC Hlavaca, LA Lacerdaa*, FO Conradob, PS Hünninga, M Seibertc, FHD Gonzálezd, U Gigere aPostgraduate Program in Veterinary Sciences, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. bVeterinary Clinic Pathology, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. cClinic Pathology, PetLab Ltda, Porto Alegre, Brasil. dDepartment of Veterinary Clinic Pathology, Faculty of Veterinary, Universidade Federal Rio Grande do Sul, Porto Alegre, RS, Brasil. eLaboratory of Genetic Diseases, University of Pennsilvania, Philadelphia, United States. RESUMEN La deficiencia de piruvato quinasa (PK) es un desorden hemolítico autosómico recesivo descrito en perros y gatos. La piruvato quinasa es una de las enzimas regulatorias esenciales de la glicólisis anaeróbica, la deficiencia de esta enzima causa una destrucción prematura de los eritrocitos. El presente es un estudio de caso y relata los hallazgos clínicos y paraclínicos en un perro brasileño de la raza West Highland White Terrier (WHWT) con historia de debilidad e intolerancia al ejercicio. El paciente presentaba mucosas pálidas, anemia hemolítica bastante regenerativa y osteoclerosis. La deficiencia de PK fue confirmada a través de una prueba de ADN raza específica para la inserción 6bp en el extremo 3’ del exón 10 de la secuencia del gen de la piruvato quinasa eritrocitaria (R-PK) como fue descrito. Al perro se le practicó eutanasia a los 20 meses de edad debido al deterioro de su estado clínico, el cual incluyó anemia e incompatibilidad sanguínea.
    [Show full text]
  • The Hematological Complications of Alcoholism
    The Hematological Complications of Alcoholism HAROLD S. BALLARD, M.D. Alcohol has numerous adverse effects on the various types of blood cells and their functions. For example, heavy alcohol consumption can cause generalized suppression of blood cell production and the production of structurally abnormal blood cell precursors that cannot mature into functional cells. Alcoholics frequently have defective red blood cells that are destroyed prematurely, possibly resulting in anemia. Alcohol also interferes with the production and function of white blood cells, especially those that defend the body against invading bacteria. Consequently, alcoholics frequently suffer from bacterial infections. Finally, alcohol adversely affects the platelets and other components of the blood-clotting system. Heavy alcohol consumption thus may increase the drinker’s risk of suffering a stroke. KEY WORDS: adverse drug effect; AODE (alcohol and other drug effects); blood function; cell growth and differentiation; erythrocytes; leukocytes; platelets; plasma proteins; bone marrow; anemia; blood coagulation; thrombocytopenia; fibrinolysis; macrophage; monocyte; stroke; bacterial disease; literature review eople who abuse alcohol1 are at both direct and indirect. The direct in the number and function of WBC’s risk for numerous alcohol-related consequences of excessive alcohol increases the drinker’s risk of serious Pmedical complications, includ- consumption include toxic effects on infection, and impaired platelet produc- ing those affecting the blood (i.e., the the bone marrow; the blood cell pre- tion and function interfere with blood cursors; and the mature red blood blood cells as well as proteins present clotting, leading to symptoms ranging in the blood plasma) and the bone cells (RBC’s), white blood cells from a simple nosebleed to bleeding in marrow, where the blood cells are (WBC’s), and platelets.
    [Show full text]
  • Laboratory Approach to Anemia Laboratory Approach to Anemia
    DOI: 10.5772/intechopen.70359 Provisional chapter Chapter 12 Laboratory Approach to Anemia Laboratory Approach to Anemia Ebru Dündar Yenilmez and Abdullah Tuli Ebru Dündar Yenilmez and Abdullah Tuli Additional information is available at the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/intechopen.70359 Abstract Anemia is a major cause of morbidity and mortality worldwide and can be defined as a decreased quantity of circulating red blood cells (RBCs). The epidemiological studies suggested that one-third of the world’s population is affected with anemia. Anemia is not a disease, but it is instead the sign of an underlying basic pathological process. However, the sign may function as a compass in the search for the cause. Therefore, the prediag- nosis revealed by thorough investigation of this sign should be supported by laboratory parameters according to the underlying pathological process. We expect that this review will provide guidance to clinicians with findings and laboratory tests that can be followed from the initial stage in the anemia search. Keywords: anemia, complete blood count, red blood cell indices, reticulocyte 1. Introduction Anemia, the meaning of which in Greek is “without blood,” is a relatively common sign and symptom of various medical conditions. Anemia is defined as a significant decrease in the count of total erythrocyte [red blood cell (RBC)] mass, although this definition is rarely used in clinical settings. According to the World Health Organization, anemia is a condition in which the number of red blood cells (RBCs, and consequently their oxygen-carrying capacity) is insufficient to meet the body’s physiologic needs [1, 2].
    [Show full text]
  • Iron Deficiency and the Anemia of Chronic Disease
    Thomas G. DeLoughery, MD MACP FAWM Professor of Medicine, Pathology, and Pediatrics Oregon Health Sciences University Portland, Oregon [email protected] IRON DEFICIENCY AND THE ANEMIA OF CHRONIC DISEASE SIGNIFICANCE Lack of iron and the anemia of chronic disease are the most common causes of anemia in the world. The majority of pre-menopausal women will have some element of iron deficiency. The first clue to many GI cancers and other diseases is iron loss. Finally, iron deficiency is one of the most treatable medical disorders of the elderly. IRON METABOLISM It is crucial to understand normal iron metabolism to understand iron deficiency and the anemia of chronic disease. Iron in food is largely in ferric form (Fe+++ ) which is reduced by stomach acid to the ferrous form (Fe++). In the jejunum two receptors on the mucosal cells absorb iron. The one for heme-iron (heme iron receptor) is very avid for heme-bound iron (absorbs 30-40%). The other receptor - divalent metal transporter (DMT1) - takes up inorganic iron but is less efficient (1-10%). Iron is exported from the enterocyte via ferroportin and is then delivered to the transferrin receptor (TfR) and then to plasma transferrin. Transferrin is the main transport molecule for iron. Transferrin can deliver iron to the marrow for the use in RBC production or to the liver for storage in ferritin. Transferrin binds to the TfR on the cell and iron is delivered either for use in hemoglobin synthesis or storage. Iron that is contained in hemoglobin in senescent red cells is recycled by binding to ferritin in the macrophage and is transferred to transferrin for recycling.
    [Show full text]
  • Microcytic Hypochromic Anemia Patients with Thalassemia: Genotyping Approach
    101 MICROCYTIC HYPOCHROMIC ANEMIA PATIENTS WITH THALASSEMIA: GENOTYPING APPROACH FAKHER RAHIM ABSTRACT BACKGROUND: Microcytic hypochromic anemia is a common condition in clinical practice, and alpha-thalassemia has to be considered as a differential diagnosis. AIMS: This study was conducted to evaluate the frequency of α-gene, β-gene and hemoglobin variant numbers in subjects with microcytic hypochromic anemia. SETTING AND DESIGNS: Population-based case-control study in the Iranian population. MATERIALS AND METHODS: A total of 340 subjects from southwest part of Iran were studied in the Research Center of Thalassemia and Hemoglobinopathies (RCTH), Iran. Genotyping for known α- and β-gene mutations was done with gap-PCR and ARMS. In cases of some rare mutations, the genotyping was done with the help of other techniques such as RFLP and ARMS-PCR. STATISTICAL ANALYSIS: Statistical analysis was carried out by SPSS 11.5 and an independent-sample t test. RESULTS: Out of the total 340 individuals, 325 individuals were evaluated to have microcytic hypochromic anemia based on initial hematological parameters such as MCV<80 fl; MCH <27 pg; the remaining 15 patients were diagnosed with no definite etiology. The overall frequency of -α3.7 deletion in 325 individuals was 20.3%. The most frequent mutations were IVS II-I, CD 36/37 and IVS I-110 with frequencies of 6.31%, 5.27% and 1.64%, respectively. Only, there was a significant difference between beta-thalassemia trait and beta-thalassemia major with regard to MCV (P < 0.05) and MCH (P < 0.05) indices, and also MCH index between beta-thalassemia trait and Hb variants (P < 0.05).
    [Show full text]
  • G6PD LEVEL DEFICIENCY in MALRIA Sarfraz Mash1, Muhammad Afzal2, Ms
    IAJPS 2019, 06 (08), 15436-15440 Sarfraz Mash et al ISSN 2349-7750 CODEN [USA]: IAJPBB ISSN: 2349-7750 INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES http://doi.org/10.5281/zenodo.3380512 Available online at: http://www.iajps.com Research Article G6PD LEVEL DEFICIENCY IN MALRIA Sarfraz Mash1, Muhammad Afzal2, Ms. Hajra Sarwar3 1 Post RN (BSN) 2nd semester student Sarfraz Mash, Lahore school of Nursing, 2 Head of Department of Lahore School of Nursing, 3 (MSN) Lahore school of Nursing. Article Received: June 2019 Accepted: July 2019 Published: August 2019 Abstract: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common hereditary enzyme disorder and morethan 200 million people have a deficiency of this enzyme. G6PD deficiency is an X-linked enzyme defect, and one of its main signs is the presence of hemolytic anemia. It is a worldwide important cause of neonatal jaundice and causes life threatening hemolytic crisis in childhood. At later ages, certain drugs such as anti-malarial drugs and fava beans cause hemolysis among G6PD deficiency patients. The frequency and severity is influenced by genetic and cultural factors. It is common in Mediterranean, African and some East Asian populations but rare in Bangladeshi peoples. Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive. Corresponding author: Sarfraz Mash, QR code Post RN (BSN) 2nd semester student Sarfraz Mash, Lahore school of Nursing. Please cite this article in press Sarfraz Mash et al., G6PD Level Deficiency In Malria., Indo Am. J. P. Sci, 2019; 06(08). www.iajps.com Page 15436 IAJPS 2019, 06 (08), 15436-15440 Sarfraz Mash et al ISSN 2349-7750 INTRODUCTION: phosphate dehydrogenase.
    [Show full text]
  • Glucose-6-Phosphate Dehydrogenase Deficiency In
    omics & en P Brito et al., J Pharmacogenomics Pharmacoproteomics 2014, 5:2 g h o a c r a m DOI: 10.4172/2153-0645.1000125 m a r c a o Journal of h p P r o f t o e l ISSN: 2153-0645o a m n r i c u s o J Pharmacogenomics & Pharmacoproteomics Research Article Article OpenOpen Access Access Glucose-6-Phosphate Dehydrogenase Deficiency in Children from 0 to 14 Years Hospitalized at the Pediatric Hospital David Bernardino, Luanda, Angola Miguel Brito1,2*, Chissengo Lucama Tchonhi3, Brigida Santos4 and Luisa Veiga1 1Lisbon School of Health Technology, Polytechnic Institute of Lisbon, Portugal 2CISA Project–Health Research Centre in Angola, Caxito, Angola 3Faculty of Medicine, University Agostinho Neto, Luanda, Angola 4Hospital Pediatrico David Bernardino, Luanda, Angola Abstract The Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic defect in the world. The most common clinical manifestations are acute hemolytic anemia associated with drugs, infections, neonatal jaundice and hemolytic non-spherocytic chronic anemia. The main aim of this study was to determine the frequency of major genetic variants of G6PD leading to enzyme deficiency in children from 0 to 14 years at a Pediatric Hospital in Luanda, Angola. A cross-sectional and descriptive analytical study covered a total of 194 children aged from 0 to 14 years, of both genders and hospitalized at the Pediatric Hospital David Bernardino, Luanda between November and December, 2011. The G202A, A376G and C563T mutations of the G6PD gene were determined by real-time PCR with Taqman probes. The disabled A-/A- genotype was detected in 10 girls (10.9%).
    [Show full text]
  • Chapter 03- Diseases of the Blood and Certain Disorders Involving The
    Chapter 3 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50- D89) Excludes2: autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) This chapter contains the following blocks: D50-D53 Nutritional anemias D55-D59 Hemolytic anemias D60-D64 Aplastic and other anemias and other bone marrow failure syndromes D65-D69 Coagulation defects, purpura and other hemorrhagic conditions D70-D77 Other disorders of blood and blood-forming organs D78 Intraoperative and postprocedural complications of the spleen D80-D89 Certain disorders involving the immune mechanism Nutritional anemias (D50-D53) D50 Iron deficiency anemia Includes: asiderotic anemia hypochromic anemia D50.0 Iron deficiency anemia secondary to blood loss (chronic) Posthemorrhagic anemia (chronic) Excludes1: acute posthemorrhagic anemia (D62) congenital anemia from fetal blood loss (P61.3) D50.1 Sideropenic dysphagia Kelly-Paterson syndrome Plummer-Vinson syndrome D50.8 Other iron deficiency anemias Iron deficiency anemia due to inadequate dietary
    [Show full text]
  • General Refugee Health Guidelines
    GENERAL REFUGEE HEALTH GUIDELINES U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Global Migration and Quarantine August 6, 2012 Background On average, more than 50,000 refugees relocate to the United States annually. 1 They come from diverse regions of the world and bring with them health risks and diseases common to all refugee populations as well as some that may be unique to specific populations. The purpose of this document is to describe general and optional testing components that do not fall into the specific disease categories of these guidelines. These guidelines are based upon principles of best practices, with references to primary published reports when available. This document differs from others in the guidelines, which recommend screening for specific disorders. The guidelines in this document include testing for abnormalities or clinical conditions that are not specific disorders but are suggestive of underlying disorders. The tests in this document may indicate either acute or chronic disorders and generally indicate the need for further testing and evaluation to identify the condition causing the abnormality. Testing for chronic health conditions is important, since these conditions are common in newly arriving refugees, both children and adults. 2 Since refugee populations are diverse and are predisposed to diseases that may differ from those found in the U.S. population, the differential diagnosis and initial evaluation of abnormalities are discussed to assist the clinician. General and Optional Tests Many disorders may be detected by using general, nonspecific testing modalities.
    [Show full text]
  • Enzymatic Defect in "X-Linked" Sideroblastic Anemia: Molecular Evidence for Erythroid 6-Aminolevulinate Synthase Deficiency PHILIP D
    Proc. Nad. Acad. Sci. USA Vol. 89, pp. 4028-4032, May 1992 Medical Sciences Enzymatic defect in "X-linked" sideroblastic anemia: Molecular evidence for erythroid 6-aminolevulinate synthase deficiency PHILIP D. COTTER*, MARTIN BAUMANNt, AND DAVID F. BISHOP*t *Division of Medical and Molecular Genetics, Mount Sinai School of Medicine, Fifth Avenue and 100th Street, New York, NY 10029; and tlI. Innere Abteilung, Krankenhaus Spandau, Lynarstrasse 12, W-1000 Berlin 20, Germany Communicated by Victor A. McKusick, January 9, 1992 ABSTRACT Recently, the human gene encoding eryth- To investigate this hypothesis, the erythroid ALAS2 cod- roid-specific -aminolevulinate synthase was localized to the ing regions were amplified and sequenced from a male chromosomal region Xp2l-Xq2l, identifying this gene as the affected with pyridoxine-responsive XLSA. In this commu- logical candidate for the enzymatic defect causing "X -linked" nication, an exonic point mutation in the ALAS2 gene that sideroblastic anemia. To investigate this hypothesis, the 11 predicted the substitution of asparagine for a highly con- exonic coding regions of the -aminolevulinate synthase gene served isoleucine is characterized as evidence that the defect were amplified and sequenced from a 30-year-old Chinese male in XLSA is the deficient activity of the erythroid form of with a pyridoxine-responsive form of X-linked sideroblastic ALAS. anemia. A single T -- A transition was found in codon 471 in a highly conserved region of exon 9, resulting in an ile -+ Asn MATERIALS AND METHODS substitution. This mutation interrupted contiguous hydropho- bic residues and was predicted to transform a region of (3-sheet Case Report.
    [Show full text]
  • The Coexistence of Polycythemia Vera and Iron Deficiency Anemia Somchai Insiripong1, Wattana Insiripong2
    CASE REPORT The Coexistence of Polycythemia Vera and Iron Deficiency Anemia Somchai Insiripong1, Wattana Insiripong2 1Department of Medicine, Saint Mary Hospital, Nakhon Ratchasima 30000, Thailand, 2Department of General Practice, NopparatRajathanee Hospital, Khanna Yao, Bangkok 10230, Thailand ABSTRACT Polycythemia vera (PV) is a clonal myeloproliferative neoplasm mainly characterized by an abnormal increase of erythroid precursor cells leading to increased red blood cells (RBC) production that is opposite to iron deficiency anemia (IDA) of which the RBC production is decreased due to iron deficiency. This report was aimed to present one patient who had coexistence of these two opposite entities of the RBC production. She was a 47-year-old Thai who was admitted because of acute coronary syndrome and she was accidentally found to have microcytosis of RBC despite normal hemoglobin (Hb) concentration, Hb 14.7 g%, mean corpuscular volume (MCV) 70.0 fL, white blood cells 12,400/mm3, and platelet 401,000/mm3. The Hb analysis showed only A2A, with normal Hb A2 percentage. The polymerase chain reaction for alpha thalassemia-1 genotype was tested negative. Due to neither alpha- nor beta-thalassemia trait detected, the iron study was performed: Serum ferritin 6.1 ng/mL, serum iron 64 ug/dl, and total iron binding capacity 198 ug/dl. The iron storage was seemingly insufficient; hence, iron supplement was started and continued for 4 months. Her blood tests showed: Hb 18.3 g%, MCV 87.2 fl, serum ferritin 31.7 ng/ml, erythropoietin <1 IU/l, positive JAK2 V617F mutation, and normal oxygen saturation. The diagnosis of PV was definitely concluded and she was finally treated with hydroxyurea and occasional phlebotomy.
    [Show full text]